- Phase I
- Phase II/III
- Therapeutic expertise
- Rescue services
- Technology solutions
- Comprehensive capabilities
- News &
Resources for Analgesia Trials
Clinical trials in pain indications present unique challenges. Rho has extensive experience addressing these challenges to set your program up for success. Here are some resources we have developed to help you:
White Paper: Considerations for Development and Approval of Analgesic Products
Dr. David Shoemaker, Senior Vice President R&D, provides an overview of the regulatory landscape for analgesic product development.
White Paper: The Minimal Clinically Important Difference in Efficacy Trials of Analgesics
Dr. Brian Boehlecke, Medical Officer, provides an overview of the literature around minimal clinically important difference as it applies to clinical trials for analgesic products.
Webinar: Stop the Pain: Tips for increasing patient retention and decreasing missing data in analgesia clinical trials
Lynn King, Assistant Vice President Operations, and Karen Kesler, Senior Statistical Scientist, share real-world solutions for trial design, execution, and analysis that will increase patient retention, minimize missing data, and help you successfully navigate FDA’s new paradigm for clinical trials in pain.